Of the 13 human cancer cell lines examined, 5 NSCLCs (NCI-H596, H358, H322, A549, and H157) and 2 colorectal cancers (HCT116 and SW620) showed approximately 20% growth reduction by SCGB3A2 + LPS (Figs. 1C and 2A and Supplementary Table S1). The gene discussed is SCGB3A2; the disease is cancer.